Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma
Mira Heinonen(University of Helsinki), Ari Ristimäki(University of Helsinki), Sung-Hee Chang(Beth Israel Deaconess Medical Center), Kirsi Narko(UConn Health), Henry Furneaux(UConn Health), Timothy Hla(Boston Children's Hospital), Johan Lundin(University of Helsinki), Heikki Joensuu(Orion Corporation (Finland)), Caj Haglund(University of Helsinki), Petri Bono(Helsinki University Hospital)
Cited by 212
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
|Pharmacological Reviews|2004|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k